4-aminoquinazoline has been researched along with Chagas Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akao, Y; Akther, T; Canan, S; Cao, Y; Chowdhury, S; Condroski, K; Engkvist, O; Francisco, A; Ghosh, S; Itono, S; Kaki, R; Kamaura, M; Kelly, JM; Kimura, C; Kogej, T; Mowbray, C; Nagaoka, K; Naito, A; Ochida, A; Pairaudeau, G; Perry, B; Radu, C; Roberts, I; Shimada, M; Shum, D; Tawaraishi, T; Watanabe, NA; Xie, H; Yonezawa, S; Yoshida, O; Yoshida, R | 1 |
1 other study(ies) available for 4-aminoquinazoline and Chagas Disease
| Article | Year |
|---|---|
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an
Topics: Chagas Disease; Humans; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2023 |